Register for our free email digests:
Celltrion Inc.
www.celltrion.com/en
Latest From Celltrion Inc.
US Biosimilar Sponsors Seek Off-The-Record Discussions
Hoping to avoid litigation discovery, sponsors ask FDA for avenue to explain patent issues during labeling discussions without written record; negotiations for BsUFA III may be opportunity to create such a process.
Biosimilar Sponsors Want Off-The-Record Labeling Discussions With US FDA
Hoping to avoid litigation discovery, sponsors ask FDA for avenue to explain patent issues during labeling discussions written record; negotiations for BsUFA III may be opportunity to create such a process.
Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News
The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.
US Trastuzumab Competition Heats Up
Mylan and Biocon have launched their Ogivri trastuzumab biosimilar in the US, marking the second biosimilar rival to Herceptin and leading a new wave of trastuzumab biosimilars expected to arrive in the US early next year.
Company Information
- Industry
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
- Contract Research, Toxicology Testing-CRO
-
Pharmaceuticals
- Generic Drugs
- Services
- Therapeutic Areas
- Cancer
- Dermatology
- Gastrointestinal
- Immune Disorders
- Infectious & Viral Diseases
- Inflammation
- Musculoskeletal & Connective Tissue Disorders
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
South Korea
-
South Korea
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Celltrion Inc.
- Senior Management
- Hyoung-Ki Kim, Co-CEO
- Contact Info
-
Celltrion Inc.
Phone: (82) 32 850 5000
23 Academy-ro
Yeonsu-gu
Incheon City, 406-840
South Korea
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice